Evaluation of an intensive strategy for follow-up and surveillance of primary breast cancer

Annals of Surgical Oncology

Volumn 5, Issue 6, 1998, Pages 522-528

  Joseph, Emmanuella ^a   Hyacinthe, Micheline ^a   Lyman, Gary H ^a   Busch, Carl ^a   Demps, LaTara ^a   Reintgen, Douglas S ^a   Cox, Charles E ^a  

^a H LEE MOFFITT CANCER CENTER AND RESEARCH INSTITUTE   (United States)

Author keywords

Breast cancer; Diagnostic test; Guidelines; Surveillance

Indexed keywords

CARCINOEMBRYONIC ANTIGEN;

ARTICLE; BONE SCINTISCANNING; BREAST CANCER; CANCER RECURRENCE; CANCER STAGING; CANCER SURVIVAL; DIAGNOSTIC APPROACH ROUTE; FEMALE; FOLLOW UP; HUMAN; INTERMETHOD COMPARISON; LABORATORY TEST; MAJOR CLINICAL STUDY; MAMMOGRAPHY; METASTASIS; PATIENT CARE; PRACTICE GUIDELINE; REGRESSION ANALYSIS;

BREAST NEOPLASMS; CANCER CARE FACILITIES; CONTINUITY OF PATIENT CARE; FLORIDA; HOSPITALS, UNIVERSITY; HUMANS; MULTIVARIATE ANALYSIS; NEOPLASM RECURRENCE, LOCAL; PRACTICE GUIDELINES; PROPORTIONAL HAZARDS MODELS; RECURRENCE; REGRESSION ANALYSIS; SURVIVAL ANALYSIS;

EID: 0031694866     PISSN: 10689265     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF02303645     Document Type: Article

References (32)

1. Horton J. Follow-up of breast cancer patients. Cancer 1984;53: 790-7.
2. Simmon MS, Hoff M, Hussien, et al. An evaluation of clinical follow-up in women with early stage breast cancer among physicians members of ASCO. Breast Cancer Res Treat 1993;1:207-11.
3. Carlson R, Goldstein LJ, McCormick B. Breast cancer practice guidelines: panel presentation. National Comprehensive Cancer Network 1996.
4. Tannock IF, Belanger D. Use of physician directed questionnaire to define a consensus about management of breast cancer: implications for assessing costs and benefits of treatment. J Natl Cancer Inst Monograph 1992;11:137-42.
5. American Society Of Clinical Oncology. Recommended Breast Cancer Surveillance Guidelines. J Clin Oncol 1997;15:2149-56.
6. Schapira DV, Urban N. A minimalist policy for breast cancer surveillance. JAMA 1991;265:380-2.
7. Shapira DW. Breast cancer surveillance - a cost-effective strategy. Breast Cancer Res Treat 1993;25:107-11.
8. Liberati A. The GIVIO trial on the impact of follow-up care on survival and quality of life in breast cancer patients. Ann Oncol 1995;6(Suppl 2):40-6.
9. The Givio Investigators. Impact of follow up testing on survival and health-related quality of life in breast cancer patients: a multicenter randomized controlled trial. JAMA 1995;271:1587-92.
10. Woolf SH. Practice guidelines, a new reality in medicine. II: Methods of developing guidelines. Arch Intern Med 1992;152:946-52.
11. Love SM, McGuigan KA, Linnea C. The Revlon/UCLA Breast Center practice guidelines for the treatment of breast disease. Cancer J Sci Am 1996;2:S2-23.
12. Paradiso A, Nitti P, Freeza P, et al. A survey in Pulgia: the attitudes and opinions of specialists, general physicians and patients on follow-up practice. Ann Oncol 1995;6(suppl 2):S53-6.
13. Orel Greenstein S, Fowble BL, Solin LJ. Breast cancer recurrence after lumpectomy and radiation therapy for early stage disease: prognostic significance of detection method. Radiology 1993;188: 189-94.
14. Crivelli D. Routine follow-up of patients after primary treatment for operable breast cancer. Ann Oncol 1995;6:769-76.
15. Rosselli Del Turco M, Palli D, Cariddi A, Ciatto S. The efficacy of intensive follow-up testing in breast cancer cases. Ann of Oncol 1995;6(suppl 2):S37-9.
16. Zwaaveling A, Albers GHR, Felthuis W. An evaluation of routine follow-up for detection of breast cancer. J Surg Oncol 1987;34: 194-7.
17. Rosselli Del Turco M, Palli D, Cariddi A, et al. Intensive diagnostic follow-up after treatment of primary breast cancer: a randomized trial. JAMA 1994;271:1593-7.
18. Gion M, Barioli P, Mione R, et al. Tumor markers in cancer follow-up: a potentially useful parameter still awaiting definitive assessment. Ann Oncol 1995;6(suppl 2):S31-5.
19. Crippa F, Bombardieri E, Seregni E, et al. Single determination of CA 15.3 and bone scintigraphy in the diagnosis of skeletal metastasis of breast cancer. J Nucl Biol Med 1992;36:52-5.
20. Beard DB, Haskell CM. Carcinoembryonic antigen in breast cancer. Am J Med 1986 80:241-5.
21. Hannisdal E, Gundersen S, Kvaloy S, et al. Follow-up of breast cancer patients stage I-IIA baseline study. Eur J Cancer 1993; 29A:992-7.
22. Waalkes TP, Enterline JP, Sharper JH, et al. Biological markers for breast carcinoma. Cancer 1984;53:644-51.
23. Khansur T, Haick A, Patel B, et al. Evaluation of bone scan as a screening work-up in primary and local-regional recurrence of breast cancer. Am J Clin Oncol 1987;10:167-70.
24. Kagan R, Steckel RJ. Routine imaging studies for the post treatment surveillance of breast and colorectal carcinoma. J Clin Oncol 1991;9:837-42.
25. Hietanen P. Chest radiography in the follow-up of breast cancer. Acta Radiol Oncol 1985;25:15-8.
26. Cox CE, Greenberg H, Fleisher D, et al. Natural history and clinical evaluation of the lumpectomy scar. Am Surg 1993;59:55-9.
27. Muller-Runkel R, Kalokhe UP. Scatter dose from tangential breast irradiation to the uninvolved breast. Radiology 1990;175:873-6
28. Harms SE, Flamig DP, Hesley KL, Evans WP. MRI of the breast. Magn Reson Q 1992;1813: 139-55.
29. Schnitt SJ, Connolly JL, Harris JR. Pathologic predictors of early local regional recurrence in Stage I and II breast cancer treated by primary radiation therapy. Cancer 1984;53:1049-57.
30. Rosen PP, Groshen S, Kinne DW. Survival and prognostic factors in node negative breast cancer: results of long-term follow-up studies. J Natl Cancer Inst Monograph 1992;11:159-62.
31. Tomiak E, Piccart M. Routine follow-up of patients after primary therapy for early breast cancer: changing concepts and challenges for the future. Ann Oncol 1993;4:199-204.
32. Grilli R, De Lena M, Paradiso A, Nitti P. A shared effort toward better quality of care. The Consensus Conference on Breast Cancer Follow-up. Ann Oncol 1995;6(suppl 2):S5-9.